SCNI News
Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing
Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed FinancingPR NewswireJERUSALEM, Oct. 20, 2026 Management estimates operating runway to late 2027, with potential...
PR Newswire
Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing
Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed FinancingPR NewswireJERUSALEM, Oct. 20, 2026 Management estimates operating runway to late 2027, with potential...
PR Newswire
Scinai Immunotherapeutics Announces Closing of $4.0 Million Financing Through a Private Placement and Warrant Inducement
Scinai Immunotherapeutics Announces Closing of $4.0 Million Financing Through a Private Placement and Warrant Inducement Scinai Immunotherapeutics Announces Closing of $4.0 Million Financing Through a Private Placement and Warrant InducementPR NewswireJERUSALEM, Oct. 16, 2026 JERUSALEM, Oct. 16...
PR Newswire
Scinai Immunotherapeutics Announces $4.0 Million Financing Through a Private Placement and Warrant Inducement
Scinai Immunotherapeutics Announces $4.0 Million Financing Through a Private Placement and Warrant Inducement Scinai Immunotherapeutics Announces $4.0 Million Financing Through a Private Placement and Warrant InducementPR NewswireJERUSALEM, October 14, 2026JERUSALEM, October 14, 2026 /PRNewswire...
PR Newswire
Why Is Scinai Immunotherapeutics Stock Gaining Tuesday?
Scinai Immunotherapeutics stock jumped 27% after securing a $5.1M biopharma manufacturing deal. Details on SCNI's major contract win.read more...
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers
Alaunos Therapeutics (NASDAQ:TCRT) shares rose 93.3% to $2.03 during Tuesday's pre-market session. The company's market cap stands at $2.6 million.
Scinai Immunotherapeutics (NASDAQ:SCNI) stock roseread more...
Benzinga
Scinai Expands CDMO Business with $5.1 Million Development and Clinical Manufacturing Agreement
Scinai Expands CDMO Business with $5.1 Million Development and Clinical Manufacturing Agreement Scinai Expands CDMO Business with $5.1 Million Development and Clinical Manufacturing AgreementPR NewswireJERUSALEM, Oct. 13, 2026Committed Customer Orders reach approximately $7.6 million, up...
PR Newswire
Scinai Regains Compliance with Nasdaq Minimum Bid Price Requirement
Scinai Regains Compliance with Nasdaq Minimum Bid Price Requirement Scinai Regains Compliance with Nasdaq Minimum Bid Price RequirementPR NewswireJERUSALEM, Sept. 21, 2026 Nasdaq confirms compliance with Listing Rule 5550(a)(2) after 19 consecutive business days with a closing bid price at or above...
PR Newswire
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers
Basel Medical Group (NASDAQ:BMGL) shares moved upwards by 59.8% to $7.32 during Monday's regular session.
Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 45.18% to $2.41. The company'sread more...
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers
Scinai Immunotherapeutics (NASDAQ:SCNI) stock moved upwards by 44.6% to $2.4 during Monday's pre-market session. The company's market cap stands at $1.1 million.
Definium Therapeutics (NASDAQ:DFTX)read more...
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers
Scinai Immunotherapeutics (NASDAQ:SCNI) shares rose 25.3% to $2.08 during Friday's after-market session. The market value of their outstanding shares is at $1.1 million.
Corbus Pharmaceuticalsread more...
Benzinga